Search results
Does Anavex Life Sciences (AVXL) Have the Potential to Rally 270.28% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Anavex Life Sciences (AVXL) points to a 270.3% upside in the...
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 6 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 5 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Is Anavex Life Sciences (AVXL) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 12 months agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Anavex Catapults On Alzheimer's Results — What The CEO Says Critics Got Wrong
Investor's Business Daily· 2 years agoAnavex Life Sciences says its experimental Alzheimer's treatment met the goals of a midstage study,...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 9 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoAnavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex...
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 5 months agoOne stock that might be an intriguing choice for investors right now is Anavex Life Sciences Corp....
Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 3 weeks agoAnavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
Zacks via Yahoo Finance· 5 months agoThe CHMP agrees that Anavex's (AVXL) blarcamesine for Alzheimer's disease is eligible for submission...